
NovaBridge Biosciences to Appoint New CFO in November
The firm adds a veteran executive to oversee capital allocation and prospective business transactions starting November 2.
Live Poll
Do you trust that biotech executives with extensive financial backgrounds effectively manage long-term shareholder value?